Active pharmaceutical ingredient: difference between revisions
Diff·revision 11 → 12·08:56, 4 Apr 2025
Difference between revision 11 and revision 12 of Active pharmaceutical ingredient. 6 lines changed; the page grew by 118 bytes.
| Revision 11 — 22:11, 22 Mar 2025 ExenatideEzra (talk) expand §The regulatory frame 3,435 bytes +567 | Revision 12 — 08:56, 4 Apr 2025 MicrodoseMagnus (talk) correct the description of the research-use-only exemption 3,553 bytes +118 | ||
|---|---|---|---|
| 39 | <ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref> | 39 | <ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref> |
| 40 | 40 | ||
| + | 41 | == See also == | |
| + | 42 | * [[Good manufacturing practice]] | |
| + | 43 | * [[Drug master file]] | |
| + | 44 | * [[Certificate of analysis]] | |
| + | 45 | * [[ISO 9001]] | |
| + | 46 | ||
| 41 | {{DEFAULTSORT:Active pharmaceutical ingredient}} | 47 | {{DEFAULTSORT:Active pharmaceutical ingredient}} |
| 42 | [[Category:Drug regulation]] | 48 | [[Category:Drug regulation]] |